PassPort Technologies
PassPort Technologies is a cutting-edge biotechnology company committed to the swift development and patient delivery of exceptional pharmaceuticals through its proprietary PassPort system. Located in San Diego, California, the company focuses on developing advanced drug delivery systems to improve global health outcomes. It collaborates with various partners, including academic institutions and pharmaceutical companies, to innovate in drug delivery and therapeutics. The company is also exploring future medication management and patient adherence solutions, integrating new wireless communication and data management technologies.
Industries
Nr. of Employees
small (1-50)
PassPort Technologies
Products
Transdermal microporation delivery platform
A platform technology that facilitates active transdermal delivery by creating micropores in the skin to enable rapid systemic absorption of therapeutic agents.
Transdermal zolmitriptan candidate (early clinical)
A transdermal formulation candidate of zolmitriptan evaluated in early-phase clinical testing that demonstrated rapid plasma detection and increased relative bioavailability versus oral tablet in interim results.
Transdermal microporation delivery platform
A platform technology that facilitates active transdermal delivery by creating micropores in the skin to enable rapid systemic absorption of therapeutic agents.
Transdermal zolmitriptan candidate (early clinical)
A transdermal formulation candidate of zolmitriptan evaluated in early-phase clinical testing that demonstrated rapid plasma detection and increased relative bioavailability versus oral tablet in interim results.
Services
In-house formulation and evaluation of transdermal drug candidates
Formulation, screening and preclinical evaluation services to assess transdermal delivery feasibility for partner compounds.
Collaborative research and partnership programs
Co-development programs with academic and industry partners to advance preclinical research and early clinical development of transdermal therapeutics.
In-house formulation and evaluation of transdermal drug candidates
Formulation, screening and preclinical evaluation services to assess transdermal delivery feasibility for partner compounds.
Collaborative research and partnership programs
Co-development programs with academic and industry partners to advance preclinical research and early clinical development of transdermal therapeutics.
Expertise Areas
- Transdermal drug delivery
- Clinical trial management (early-phase)
- Formulation development for transdermal systems
- Medical device development for drug delivery
Key Technologies
- Transdermal microporation
- Active transdermal delivery systems
- Lipid-mediated mRNA delivery (collaborative application)
- Pharmacokinetic bioavailability assays